Aurora Cannabis Inc. (ACB)
收市後：
| 前收市價 | 7.42 |
| 開市 | 7.26 |
| 買盤 | 7.13 x 1700 |
| 賣出價 | 7.26 x 900 |
| 今日波幅 | 7.04 - 7.48 |
| 52 週波幅 | 2.84 - 11.50 |
| 成交量 | |
| 平均成交量 | 5,968,304 |
| 市值 | 392.684M |
| Beta 值 (5 年，每月) | 2.93 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -57.81 |
| 業績公佈日 | 2024年6月12日 - 2024年6月17日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 32.16 |
ZacksHas Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
Here is how Adverum Biotechnologies (ADVM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.
ZacksAurora Cannabis Inc. (ACB) Suffers a Larger Drop Than the General Market: Key Insights
Aurora Cannabis Inc. (ACB) concluded the recent trading session at $6.46, signifying a -1.15% move from its prior day's close.
InvestorPlace3 Short-Squeeze Stocks to Buy for 100% Returns in Q2 2024
In the world of investing, no single rule needs to be followed. Whether technical, fundamentals, short-term trading or long-term investing, the bottom line is generating returns that consistently beat the index. One strategy that has worked in the last few years to generate quick returns is exposure to short-squeeze stocks. The idea emerged during the euphoric rally for penny and meme stocks in 2021. The underlying logic is considering exposure to stocks where sentiments are overly bearish. The
